Unilateral Primary Aldosteronism, Mineralocorticoid Antagonists Versus Surgical Treatment
Status:
Not yet recruiting
Trial end date:
2027-02-01
Target enrollment:
Participant gender:
Summary
This is a prospective randomized controlled trial where quality of life and the effectiveness
of treatment will be evaluated in 80 patients with confirmed unilateral primary aldosteronism
,randomly assigned to be either treated surgically with unilateral adrenalectomy or to
receive medical treatment with eplerenone.